Intraventricular immunovirotherapy; a translational step forward

Oncolytic virotherapy with intratumoral engineered type-1 herpes simplex virus (HSV) has been proven safe with promising efficacy in recent clinical trials for treatment of both pediatric and adult high-grade glioma. However, this approach excludes patients with tumors in surgically inaccessible and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstock, Joshua D., Blitz, Sarah, Kang, Kyung-Don, Friedman, Gregory K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836381/
https://www.ncbi.nlm.nih.gov/pubmed/36634220
http://dx.doi.org/10.18632/oncotarget.28343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836381/
https://www.ncbi.nlm.nih.gov/pubmed/36634220
http://dx.doi.org/10.18632/oncotarget.28343

Ejemplares similares